Elucidata Expands Leadership Team with AI and Biotech Experts

Author

Slice of Technology Team
March 03, 2025

Key Highlights:

  • Elucidata appoints Dr. Werner Lanthaler as Independent Board Member and Dr. Navjot Singh as Advisor.

  • Recognized as Fast Company’s Most Innovative Biotech Company and winner of National Cancer Institute's AI-Readiness Challenge.

  • Dr. Lanthaler brings biotech leadership and innovation expertise from Evotec SE and Wlanholding.

  • Dr. Singh, a Senior Partner Emeritus at McKinsey & Co., specializes in AI, healthcare, and digital transformation.

  • Elucidata advances AI-ready data solutions, ensuring data quality as a service for biopharma R&D.

Source: Business Wire

Notable Quotes:

❝

“Elucidata is on a strong growth trajectory, enabling biopharma R&D organizations to fully realize the potential of AI.”

Dr. Werner Lanthaler, Independent Board Member at Elucidata
❝

“Elucidata addresses AI’s biggest challenge—turning fragmented and unstructured data into high-quality assets.”

Dr. Navjot Singh, Advisor at Elucidata

Why This Matters:

As AI reshapes life sciences, healthcare, and diagnostics, data quality remains a critical challenge. Elucidata’s human-in-the-loop approach and cutting-edge AI solutions ensure that organizations can accelerate innovation with reliable, AI-ready data. The addition of Dr. Lanthaler and Dr. Singh strengthens Elucidata’s leadership, positioning it to drive breakthroughs in precision medicine and biopharma R&D.

Reply

or to participate.